Biopartners Holdings AG Purchased by Bioton S.A.

16-Mar-2007

Biopartners Holdings AG has announced that it has been purchased in a deal worth $78M by Bioton S.A., a Polish biotechnology company. Bioton S.A., and entities associated with DLJ Merchant Banking Partners signed a purchase agreement for 100% shares in share capital on 9th March 2007, including the subsidiaries Biopartners GmbH (Switzerland) and Biopartners GmbH (Germany).

Biopartners is a biotechnology company concentrating on the development of innovative drugs and biopharmaceuticals, where significant market opportunities exist. According to the company, the terms of the deal ensure that all Biopartners' operations remain untouched, with all drug development projects continuing as before under the same management.

Bioton S.A. is a Polish company in the biotechnology sector, manufacturing modern drugs, including recombinant human insulin and its pharmaceutical forms, as well as preparations from the cephalosporine, aminoglycoside and macrolide groups.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances